Relation between polymorphisms G1704T and G82S of rage gene and diabetic retinopathy in Japanese type 2 diabetic patients

Intern Med. 2005 May;44(5):417-21. doi: 10.2169/internalmedicine.44.417.

Abstract

Objective: To clarify whether polymorphisms G1704T and G82S of the rage gene were related to diabetic retinopathy, we performed a case-control study in Japanese type 2 diabetic patients.

Patients and methods: Two hundred and sixty-eight patients with type 2 diabetes were examined for polymorphisms G1704T and G82S of the RAGE gene. The genotypes of G1704T and G82S of the RAGE gene were determined with a fluorescent allele-specific DNA primer assay system. Diabetic retinopathy (DR) was diagnosed in a masked manner by independent ophthalmologists using fundus photographs and was classified as non-diabetic retinopathy (NDR), non-proliferative retinopathy (NPDR), and proliferative retinopathy (PDR).

Results: The T allele frequency of G1704T and S allele frequency of G82S in patients with DR did not significantly differ from those without retinopathy. There were no differences among the genotypes of G1704T and G82S of the RAGE gene regarding age, duration of diabetes, BMI, HbA(1c), blood pressure, and lipids levels.

Conclusion: These data suggest that polymorphisms G1704T and G82S of the RAGE gene are not related to DR in Japanese type 2 diabetic patients.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Alleles
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetic Retinopathy / epidemiology
  • Diabetic Retinopathy / etiology
  • Diabetic Retinopathy / genetics*
  • Female
  • Gene Frequency
  • Genetic Markers / genetics
  • Genotype
  • Glycated Hemoglobin / metabolism
  • Humans
  • Japan / epidemiology
  • Lipids / blood
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide*
  • Prevalence
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic / genetics*
  • Risk Factors

Substances

  • Genetic Markers
  • Glycated Hemoglobin A
  • Lipids
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic